Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 225Generated: October 26, 2026

4-Bromo-2-nitroanisole → cis-3,5-Dimethyl-1-[4-(methyloxy)-3-nitrophenyl]piperazine

https://huagongshe.com/reaction/225

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-Bromo-2-nitroanisoleHCID 118533—
Reactantrel-(2R,6S)-2,6-dimethylpiperazineHCID 6950261—
ReagentCesium carbonateHCID 10796—
CatalystBinap, (A+-)-HCID 634876—
CatalystPalladium (II) acetateHCID 4144353—
Solvent1,4-DioxaneHCID 31275—
Productcis-3,5-Dimethyl-1-[4-(methyloxy)-3-nitrophenyl]piperazineHCID 5900705255.97%

Reaction Conditions

Temperature100 °C

Reaction Steps

To a solution of 4-bromo-1-methoxy-2-nitrobenzene (150 mg, 0.65 mmol) in dioxane (4 mL) was added (2R,6S)-2,6-dimethylpiperazine (221 mg, 1.94 mmol) followed by cesium carbonate (316 mg, 0.97 mmol), 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (56.4 mg, 0.09 mmol) and diacetoxypalladium (14.51 mg, 0.06 mmol). The resulting mixture was heated at 100 °C under argon over night (black). LCMS Ok. The solids were filtered through celite and washed with ethyl acetate. The ethyl acetate was evaporated under reduced pressure and the crude product was purified by flash- chromatograpy eluated with dichloromethane/ Methanol + 0.2% Et3N 100/0 =>90/10 over 20 min. The pure fractions was collected and concentrated to give (3R,5S)-1-(4-methoxy-3-nitrophenyl)-3,5-dimethylpiperazine (96 mg, 56.0 %) as red solid.

Provenance & Evidence

Source dataset750 AstraZeneca ELN dataset
ORD IDord-fb5c3a40f09e4b5fab2cf5db4493aed4
Source note750 AstraZeneca ELN dataset